How do I install the Endo Vitd No Screening Dark Complexion skill?

Run npx skillmds@latest add dromlakhani/endo-vitd-no-screening-dark-complexion in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Endo Vitd No Screening Dark Complexion safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: makes network calls. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Endo Vitd No Screening Dark Complexion?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Endo Vitd No Screening Dark Complexion free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Endo Vitd No Screening Dark Complexion?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Endo Vitd No Screening Dark Complexion by dromlakhani

Name: Endo Vitd No Screening Dark Complexion
Rating: 4.666666666666667 (3 reviews)
Author: dromlakhani

Endo Vitd No Screening Dark Complexion

The guideline recommends against routine 25(OH)D screening and subsequent vitamin D treatment in adults with dark complexion who lack established indications for testing. Consider this recommendation when clinicians ask, "Should I screen for vitamin D deficiency in this patient with dark skin?" or "Is vitamin D testing indicated based on skin complexion?"

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Against routine vitamin D screening in dark complexion adults

STEP 1 — Gather Information

Collect patient age, observed or self-reported dark complexion (e.g., Fitzpatrick V-VI), presence of established indications for 25(OH)D testing (hypocalcemia, malabsorption, chronic kidney disease, etc.), and pregnancy status. Action: If the patient is an adult with dark complexion and lacks established indications for testing, proceed to Step 2.

STEP 2 — Rule In / Rule Out

If any established indication for 25(OH)D testing is present (e.g., hypocalcemia, malabsorption, renal osteodystrophy), rule in: proceed to targeted testing per standard of care (outside this guideline). Otherwise, rule out routine screening and proceed to Step 3.

STEP 3 — Classify or Stratify

Classify the patient as a candidate for empiric vitamin D supplementation only if they belong to a group with a guideline recommendation for empiric supplementation (age 1‑18 years, ≥75 years, pregnancy, or high‑risk prediabetes); otherwise classify as not indicated for empiric supplementation. Action: If classified as a candidate for empiric supplementation, proceed to Step 4A; if not, proceed to Step 4B.

STEP 4 — Decide

4A: For candidates for empiric supplementation, initiate age‑appropriate empiric vitamin D dosing (per guideline) without prior 25(OH)D testing. 4B: For those not meeting empiric supplementation criteria, do not order 25(OH)D testing and do not initiate empiric vitamin D supplementation; advise on dietary sources and safe sun exposure as needed.

Clinical Guardrails / Mimics / Pitfalls

Do not use race as a proxy for dark complexion; assess skin pigmentation directly. Do not extrapolate to patients with conditions that alter vitamin D metabolism (e.g., malabsorption, renal disease). Do not order 25(OH)D testing based solely on skin complexion. Do not initiate high‑dose intermittent vitamin D without a specific indication. Do not assume low 25(OH)D levels based on complexion alone.

Concrete Clinical Example

A 55‑year‑old African American woman with Fitzpatrick skin type VI presents for a routine preventive visit. She denies symptoms of hypocalcemia, malabsorption, or bone pain and asks whether she should be checked for vitamin D deficiency. Following the guideline, we advise against routine 25(OH)D screening; we note that empiric supplementation is not recommended for her age group without other indications, and we counsel on dietary vitamin D sources and safe sun exposure.

Source: Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, https://doi.org/10.1210/clinem/dgae290

---name: endo-vitd-no-screening-dark-complexiondescription: The guideline recommends against routine 25(OH)D screening and subsequent vitamin D treatment in adults with dark complexion who lack established indications for testing. Consider this recommendation when clinicians ask, "Should I screen for vitamin D deficiency in this patient with dark skin?" or "Is vitamin D testing indicated based on skin complexion?"---# Against routine vitamin D screening in dark complexion adults## STEP 1 — Gather InformationCollect patient age, observed or self-reported dark complexion (e.g., Fitzpatrick V-VI), presence of established indications for 25(OH)D testing (hypocalcemia, malabsorption, chronic kidney disease, etc.), and pregnancy status.Action: If the patient is an adult with dark complexion and lacks established indications for testing, proceed to Step 2.## STEP 2 — Rule In / Rule OutIf any established indication for 25(OH)D testing is present (e.g., hypocalcemia, malabsorption, renal osteodystrophy), rule in: proceed to targeted testing per standard of care (outside this guideline). Otherwise, rule out routine screening and proceed to Step 3.## STEP 3 — Classify or StratifyClassify the patient as a candidate for empiric vitamin D supplementation only if they belong to a group with a guideline recommendation for empiric supplementation (age 1‑18 years, ≥75 years, pregnancy, or high‑risk prediabetes); otherwise classify as not indicated for empiric supplementation.Action: If classified as a candidate for empiric supplementation, proceed to Step 4A; if not, proceed to Step 4B.## STEP 4 — Decide4A: For candidates for empiric supplementation, initiate age‑appropriate empiric vitamin D dosing (per guideline) without prior 25(OH)D testing.4B: For those not meeting empiric supplementation criteria, do not order 25(OH)D testing and do not initiate empiric vitamin D supplementation; advise on dietary sources and safe sun exposure as needed.## Clinical Guardrails / Mimics / PitfallsDo not use race as a proxy for dark complexion; assess skin pigmentation directly. Do not extrapolate to patients with conditions that alter vitamin D metabolism (e.g., malabsorption, renal disease). Do not order 25(OH)D testing based solely on skin complexion. Do not initiate high‑dose intermittent vitamin D without a specific indication. Do not assume low 25(OH)D levels based on complexion alone.## Concrete Clinical ExampleA 55‑year‑old African American woman with Fitzpatrick skin type VI presents for a routine preventive visit. She denies symptoms of hypocalcemia, malabsorption, or bone pain and asks whether she should be checked for vitamin D deficiency. Following the guideline, we advise against routine 25(OH)D screening; we note that empiric supplementation is not recommended for her age group without other indications, and we counsel on dietary vitamin D sources and safe sun exposure.**Source:** Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, https://doi.org/10.1210/clinem/dgae290

Frequently asked questions